← Back to Clinical Trials
Recruiting NCT06365151

NCT06365151 An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06365151
Status Recruiting
Phase
Sponsor Universitat de Lleida
Condition Fibromyalgia
Study Type INTERVENTIONAL
Enrollment 114 participants
Start Date 2024-04-05
Primary Completion 2025-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Osteopathic manual therapySham osteopathic manual therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 114 participants in total. It began in 2024-04-05 with a primary completion date of 2025-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Nowadays, fibromyalgia is the rheumatic disorder with the highest levels of deterioration in quality of life. Among the comorbidities it presents, one of the most frequent is temporomandibular disorders. A randomized clinical study will be conducted to evaluate the effectiveness of an osteopathic manual therapy approach algorithm in a group of patients with fibromyalgia and temporomandibular disorders.

Eligibility Criteria

Inclusion Criteria: * be diagnosed as suffering from fibromyalgia, * present moderate pain or dysfunction of more than 3 months' duration in the temporomandibular joint, * be over 18 years old, * understand Spanish and/or Catalan correctly, * and read and accept the informed consent form Exclusion Criteria: * history of trauma or recent surgery to the head, face or neck; * systemic, rheumatic or central nervous system diseases; * diagnosis of malignant tumors or cancer in the orofacial region; * participate in other studies at the same time.

Contact & Investigator

Central Contact

Llanos de la Iglesia, MsC

✉ llanos.delaiglesia@gmail.com

📞 +4679536992

Principal Investigator

Llanos de la Iglesia

PRINCIPAL INVESTIGATOR

Departament de infermeria i fisioterapia. universitat de Lleida

Frequently Asked Questions

Who can join the NCT06365151 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06365151 currently recruiting?

Yes, NCT06365151 is actively recruiting participants. Contact the research team at llanos.delaiglesia@gmail.com for enrollment information.

Where is the NCT06365151 trial being conducted?

This trial is being conducted at Cornellà de Llobregat, Spain.

Who is sponsoring the NCT06365151 clinical trial?

NCT06365151 is sponsored by Universitat de Lleida. The principal investigator is Llanos de la Iglesia at Departament de infermeria i fisioterapia. universitat de Lleida. The trial plans to enroll 114 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology